| Tigit- And Light-Based Chimeric Proteins |
2022-8-18 |
2022-11-10 |
|
| Csf1r-based chimeric proteins |
2022-8-04 |
2022-10-17 |
|
| Heterodimeric proteins for modulating gamma delta t cells |
2022-6-01 |
2023-1-19 |
|
| Tgfbr2-based chimeric proteins |
2022-5-20 |
2023-2-16 |
|
| Nk cell-directed chimeric proteins |
2022-4-14 |
2023-2-16 |
|
| Pd-1- and ox40l-based chimeric proteins |
2022-4-01 |
2022-11-10 |
|
| Gamma delta t-cell costimulation |
2022-3-16 |
2022-9-22 |
|
| Chimeric proteins in autoimmunity |
2022-3-08 |
2022-9-15 |
|
| Combination therapies with sirp alpha-based chimeric proteins |
2022-3-04 |
2022-9-09 |
|
| Combination therapies with tim-3-based chimeric proteins |
2022-3-04 |
2022-9-09 |
|
| Mutant pd-1 extracellular domains |
2022-3-03 |
2022-10-06 |
|
| Methods of treating cancer using tigit-and light-based chimeric proteins |
2021-12-03 |
2022-6-09 |
|
| Methods of identifying gamma delta t cell-modulating agents |
2021-11-18 |
2022-5-27 |
|
| Vsig8-based chimeric proteins |
2021-11-01 |
2022-4-21 |
|
| Clinical dosing of sirp1a chimeric protein |
2021-9-17 |
2022-3-24 |
|
| Clinical dosing of sirp1a chimeric protein |
2021-9-17 |
2022-3-24 |
|
| Homodimeric and heterodimeric proteins comprising butyrophilin |
2021-4-14 |
2022-5-05 |
|
| Heterodimeric proteins and uses thereof |
2021-3-24 |
2021-7-15 |
|
| Combination therapies |
2021-3-10 |
2021-4-08 |
|
| Combination therapies comprising tim- 3-based chimeric proteins |
2021-2-25 |
2021-4-29 |
|
| Combination therapies comprising pd-1-based chimeric proteins |
2021-2-25 |
2021-4-29 |
|
| Flt3l-based chimeric proteins |
2021-2-24 |
2021-4-29 |
|
| Chimeric proteins in autoimmunity |
2020-8-28 |
2022-9-29 |
|
| Flt3l-based chimeric proteins |
2020-8-13 |
2021-2-18 |
|
| Chimeric protein expressing t-cells |
2020-6-22 |
2022-8-18 |
|
| Heterodimeric proteins for modulating gamma delta t cells |
2020-6-03 |
2020-10-01 |
|
| Combination therapies |
2020-2-27 |
2023-3-29 |
|
| HETERODIMERIC PROTEINS FOR MODULATION OF T GAMMA DELTA CELLS |
2020-1-07 |
2021-9-28 |
|
| Combination therapies comprising sirp alpha-based chimeric proteins |
2019-9-16 |
2020-3-05 |
|
| Chimeric proteins comprising extracellular domains and uses thereof |
2019-8-29 |
2020-3-05 |
|
| Dosage clinique de proteine chimerique sirp1a |
2021-9-17 |
2022-3-24 |
|
| Proteínas heterodiméricas para modulação de células t gama delta |
2020-1-07 |
2021-9-28 |
|